Lidocaine’s potential role in treating head and neck squamous cell carcinoma Lidocaine, a common local anesthetic, has been found to induce apoptosis in head and neck squamous cell carcinoma (HNSCC) by activating the bitter taste receptor T2R14. This activation triggers…
OSE Immunotherapeutics has received a French government grant to support a Phase III clinical trial for its cancer vaccine, Tedopi. The trial will focus on patients with advanced non-small cell lung cancer (NSCLC) who have not responded to previous treatments.…
A 67-year-old man in the UK has become the first participant in a trial for a new lung cancer vaccine, BNT116, developed by BioNTech. The vaccine, which uses mRNA technology similar to COVID-19 vaccines, aims to instruct the immune system…
Researchers at the Harry Perkins Institute and The University of Western Australia found that honeybee venom and its main molecule, melittin quickly destroys two aggressive forms of breast cancer, triple-negative and HER2-enriched, while sparing healthy breast cells. Melittin breaks open…